Tonix Pharmaceuticals (NASDAQ:TNXP) Announces Quarterly Earnings Results

Share on StockTwits

Tonix Pharmaceuticals (NASDAQ:TNXP) released its quarterly earnings data on Monday. The company reported ($0.95) earnings per share for the quarter, topping the consensus estimate of ($0.96) by $0.01, Bloomberg Earnings reports.

Tonix Pharmaceuticals stock opened at $0.46 on Wednesday. The business has a fifty day simple moving average of $0.83. Tonix Pharmaceuticals has a 12 month low of $0.43 and a 12 month high of $15.70. The company has a market cap of $6.90 million, a price-to-earnings ratio of -0.02 and a beta of 1.54. The company has a current ratio of 9.54, a quick ratio of 9.54 and a debt-to-equity ratio of 0.01.

TNXP has been the subject of a number of analyst reports. Roth Capital raised Tonix Pharmaceuticals from a “neutral” rating to a “buy” rating and set a $4.00 price objective for the company in a research report on Thursday, April 18th. ValuEngine lowered Tonix Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Wednesday, July 17th.

Tonix Pharmaceuticals Company Profile

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products to improve biodefense. Its lead product candidate is Tonmyar (TNX-102 SL), a proprietary low-dose cyclobenzaprine and sublingual tablet as a bedtime administration, which is in Phase III development for the treatment of posttraumatic stress disorder (PTSD) and Fibromyalgia; and Phase II development for the treatment of agitation in Alzheimer's disease.

Featured Article: Swap

Earnings History for Tonix Pharmaceuticals (NASDAQ:TNXP)

Receive News & Ratings for Tonix Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tonix Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

State Board of Administration of Florida Retirement System Lowers Stock Holdings in Torchmark Co.
State Board of Administration of Florida Retirement System Lowers Stock Holdings in Torchmark Co.
Securian Asset Management Inc Grows Stock Position in Viacom, Inc.
Securian Asset Management Inc Grows Stock Position in Viacom, Inc.
Zacks: Analysts Expect Santander Consumer USA Holdings Inc  to Post $0.67 Earnings Per Share
Zacks: Analysts Expect Santander Consumer USA Holdings Inc to Post $0.67 Earnings Per Share
Dynavax Technologies Co.  Receives Average Rating of “Buy” from Analysts
Dynavax Technologies Co. Receives Average Rating of “Buy” from Analysts
Cara Therapeutics Inc  Expected to Announce Earnings of -$0.59 Per Share
Cara Therapeutics Inc Expected to Announce Earnings of -$0.59 Per Share
Essential Properties Realty Trust Inc  Receives Consensus Recommendation of “Hold” from Analysts
Essential Properties Realty Trust Inc Receives Consensus Recommendation of “Hold” from Analysts


© 2006-2019 Ticker Report